山东大学耳鼻喉眼学报 ›› 2015, Vol. 29 ›› Issue (6): 36-38.doi: 10.6040/j.issn.1673-3770.0.2015.202

• 论著 • 上一篇    下一篇

肺癌肿瘤抑制因子-1在喉鳞癌组织中的表达及其意义

李富1, 赵书佑2   

  1. 1. 包头医学院第一附属医院耳鼻咽喉科, 内蒙古 包头 014010;
    2. 青岛市立医院耳鼻喉头颈外科, 山东 青岛 266011
  • 收稿日期:2015-05-25 出版日期:2015-12-16 发布日期:2015-12-16
  • 通讯作者: 赵书佑. E-mail:13606420458m0@sina.cn E-mail:13606420458m0@sina.cn
  • 作者简介:李富. E-mail:lifu5088@126.com

Expression of tumor suppressor in lung cancer 1 in laryngeal squamous cell carcinoma and its significance

LI Fu1, ZHAO Shuyou2   

  1. 1. Department of Otolaryngology, First Affiliated Hospital of Baotou Medical College, Baotou 014010, Inner Mongolia, China;
    2. Department of Otolaryngology & Head and Neck Surgery, Qingdao Municipal Hospital, Qingdao 266011, Shandong, China
  • Received:2015-05-25 Online:2015-12-16 Published:2015-12-16

PDF (PC)

372

摘要： 目的 研究肺癌肿瘤抑制因子-1(TSLC1)在喉鳞癌组织和癌旁正常组织的表达,探讨TSLC1与喉鳞癌的相关性,以期为喉癌的病因、诊断及治疗提供理论依据.方法 取喉鳞状细胞癌组织标本蜡块45例,其中8例有淋巴结转移.取20例癌旁正常组织标本蜡块作为对照.应用免疫组化PV-6000二步法测定二者中TSLC1的表达,分析TSLC1的表达水平与各临床病理参数的关系.结果用SPSS 10.0统计软件进行统计学分析.结果 TSLC1在喉鳞癌标本中的阳性表达率为17/45(37.8%),明显低于癌旁正常组织中TSLC1的阳性表达率15/20(75.0%),二者比较差异有统计学意义(χ2=7.68, P<0.01).TSLC1的表达下降与喉鳞癌的临床分期、分化程度、淋巴结转移情况差异有统计学意义(χ2=4.15、6.11、4.11, P<0.05),而与年龄、发病部位及性别差异无统计学意义(χ2=0.25、0.09、1.0, P>0.05).结论 TSLC1在喉鳞癌中表达下降,且与喉鳞癌的临床分期、分化程度、淋巴结转移情况有相关性.TSLC1在喉鳞癌中的表达下降可能与喉鳞癌的发生和侵袭有关,但需扩大样本进一步研究.

关键词: 喉鳞状细胞癌, 免疫组织化学, 肺癌肿瘤抑制因子-1

Abstract: Objective To investigate the correlation of tumor suppressor in lung cancer 1 (TSLC1) and laryngeal squamous cell carcinoma, in order to provide a theoretic basis of oncogenesis, diagnosis and treatment of laryngeal cancer. Methods Paraffin-embedded specimens were collected from 45 cases of laryngeal squamous cell carcinoma, 8 of which had lymphatic metastasis. Another 20 specimens from normal adjacent tissues served as controls. The expression of TSLC1 was detected with immunohistochemical staining (PV-6000). The relation between TSLC1 expression and other clinicopathological parameters was analyzed with SPSS 10.0. Results The positive expression of TSLC1 was 17/45 (37.8%) in specimens of laryngeal squamous cell carcinoma, which was significantly lower than in specimens of normal adjacent tissues (15/20, 75%), (χ2=7.68, P<0.01). Loss of TSLC1 expression was correlated with the clinical stage, tumor differentiation and lymph node metastasis (χ2=4.15, 6.11, 4.11, P<0.05), but not correlated with patients' age, gender, or location of primary laryngeal carcinoma (χ2= 0.25, 0.09, 1.0, P>0.05). Conclusion Loss of TSLC1 expression is frequently observed in laryngeal squamous cell carcinoma, which is significantly correlated to the clinical stage, tumor differentiation and lymph node metastasis. The down-regulation of TSLC1 expression may correlate with the occurrence and invasion of laryngeal squamous cell carcinoma, but more studies are needed to verify the hypothesis.

Key words: Laryngeal carcinoma, Tumor suppressor in lung cancer 1, Immunohistochemistry

中图分类号: 

  • R739.65
[1] 黄选兆, 汪吉宝. 实用耳鼻咽喉科学[M]. 北京: 人民卫生出版社, 1998: 502-508.
[2] Goto A, Niki T, Chi-Pin L, et al. Loss of TSLC expression in lung adenocarcinoma: relationships with histological subtypes, sex and prognostic significance[J]. Cancer Sci, 2005, 96(8):480-486.
[3] [JP2]Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer[J]. World J Gastroenterol, 2006, 12(2):192-198.
[4] Uchino K, Ito A, Wakayama T, et al. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung[J]. Cancer, 2003, 98(5):1002-1007.
[5] Lung H L, Cheung A K, Xie D, et al. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma[J]. Cancer Res, 2006, 66(19):9385-9392.
[6] Liu D, Feng X, Wu X, et al. Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma[J]. Tumour Biol, 2013, 34(6):3773-3783.
[7] Fukuhara H, Kuramochi M, Fukami T, et al. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer[J]. Jpn J Cancer Res, 2002, 93(6):605-609.
[8] Allinen M, Peri L, Kujala S, et al. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation[J]. Genes Chromosomes Cancer, 2002, 4(4):384-389.
[9] Ito T, Shimada Y, Hashimoto Y, et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma[J]. Cancer Res, 2003, 63(19):6320-6326.
[10] Zhang J, Ning J, Geng J, et al. Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer[J]. J Mol Histol, 2012, 43(6):715-721.
[1] 胡祎,孔旭辉. 补体在喉鳞状细胞癌发生发展中作用机制的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 148-155.
[2] 沈文浩,陈曦. 双能CT在喉鳞状细胞癌诊疗中的运用[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 156-160.
[3] 杨鸣,刘雪霞,张华. m6A识别蛋白IGF2BPs家族在头颈肿瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 153-161.
[4] 毕恒,谢佳,龚辉成. p-mTOR、p-S6K在鼻腔鼻窦内翻性乳头状瘤中的高表达及临床价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 25-34.
[5] 李亚茹,许贞菊,王效军,付涛,袁玥,吴策. 双颈部及鼻咽部Rosai-Dorfman病1例相关病例回顾[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 108-114.
[6] 吴彬,周敬淳. 单细胞测序分析喉鳞状细胞癌细胞RPN2表达模式[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 1-11.
[7] 王凯健,陈雪生,王威. 血小板-淋巴细胞比值与喉鳞状细胞癌预后相关性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 67-73.
[8] 张永红,张辉,王彩华,杨欣欣,吴允刚,赵玉凤,庞太忠,李晓瑜. 基于TCGA数据库构建喉鳞状细胞癌免疫相关基因预后模型及筛选靶向分子药物[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 54-62.
[9] 黄恒丰,马鲲鹏,杨迪,张丽君,张盛林. miR-181b-5P和EPB41L3蛋白在喉癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 41-46.
[10] 刘勇,袁存立,曹慧,郑成彩,晁方, 许风雷. CHD1L通过EMT促进喉鳞状细胞癌细胞的增殖、侵袭和转移[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 32-39.
[11] 薛刚,孙新民,林旭,吴靖芳. KCNK5双孔钾通道蛋白在甲状腺乳头状癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 64-69.
[12] 范义燕,张肖林,刘秀珍,尹晶晶,袁进,王延飞,陈军. CPS1在喉鳞癌组织中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 72-76.
[13] 陈慧君,宋圣花,董伟达,周涵. 术前外周血纤维蛋白原水平对喉癌预后的影响[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 110-114.
[14] 蒋宁宁,王鹏来,袁长勇,黄晓峰,蒋常委,刘宗响,孙铁忠. 肿瘤转移抑制蛋白在舌鳞状细胞癌中的表达与临床意义[J]. 山东大学耳鼻喉眼学报, 2019, 33(6): 64-67.
[15] 李浩,李延忠,王岩. HIF-1α、VEGF在阻塞性睡眠呼吸暂停低通气综合征患者[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 43-47.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发